All pairs

Glecaprevir–pibrentasvir and Rifampin

Desk tier: Avoid together

Mechanism: strong CYP3A4 induction of clearance (↓ exposure / loss of efficacy)

“MAVYRET is contraindicated with atazanavir or rifampin”
Mavyret (glecaprevir/pibrentasvir), section 4 CONTRAINDICATIONS. DailyMed label

Open this pair in the desk

All pairs for Glecaprevir–pibrentasvir · Rifampin

Enzyme behind this pair: CYP3A4

Educational reference only. Not FDA-cleared. The Prescribing Information governs.